Jonathan Paul Stoye

Title: The Innovations of Jonathan Paul Stoye

Introduction

Jonathan Paul Stoye is a prominent inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in understanding genetic factors related to obesity and retroviral subtypes. With a total of 2 patents, his work has implications for both human health and scientific research.

Latest Patents

Stoye's latest patents include groundbreaking inventions. The first patent, titled "Obesity gene," describes a previously unknown gene, termed 5'OT-EST, which is responsible for inducing an obesity and/or infertility phenotype in transgenic animals. This invention also includes transgenic animals comprising mutants of 5'OT-EST, which are useful for assaying compounds for the treatment of obesity and/or infertility. The second patent, "Detection of retroviral subtypes based upon envelope specific sequences," is based on the finding that porcine endogenous retroviruses exist in two different subtypes, termed PERV-A and PERV-B. The differences in sequence divergence in the envelope genes allow for the development of nucleic acid and antibody probes that can distinguish between the two subtypes, enabling monitoring of subtype transmission between cells, particularly from porcine to human cells.

Career Highlights

Stoye is affiliated with the Medical Research Council, where he conducts his research. His work has been instrumental in advancing our understanding of genetic influences on health and disease.

Collaborations

He has collaborated with notable colleagues, including Robin Anthony Weiss and Iain Clive Andrew Franklin Robinson, further enhancing the impact of his research.

Conclusion

Jonathan Paul Stoye's innovative contributions to medical research highlight the importance of genetic studies in addressing health issues such as obesity and viral infections. His patents reflect a commitment to advancing scientific knowledge and improving health outcomes.